PaulFriedman_SOT_2018_APCRA_CaseStudy_v2_chemcensored.pdf (1.87 MB)

Examining the Utility of In Vitro Bioactivity as a Conservative Point of Departure: A Case Study

presentation

posted on 2018-07-30, 19:42 authored by Katie Paul-Friedman, Russell Thomas

Presentation at RIVM (Netherlands National Institute for Public Health and the Environment) visit to EPA April 2018

History

Usage metrics

Center for Computational Toxicology and Exposure

Categories

Toxicology (incl. clinical toxicology)

Keywords

bioactivity data high-throughput toxicokinetics ToxCast point of departure Toxicology

Licence

Exports